1. Smellie W S A, Wilson D, Finnegan D I. et al Best practice in pathology. Methodology for constructing guidance. J Clin Pathol 2005. 58249–253.253. [PMC free article] [PubMed] 2. Sicherer S H. Manifestations of food allergy: evaluation and management [review]. Am Fam Physician 1999. 59415–24 pp 429-30.24 pp 429-30. [PubMed] 3. Saarinen U M, Juntunen K, Kajosaari M. et al Serum IgE in atopic and non‐atopic children aged 6 months to 5 years. A follow‐up study. Acta Paediatr Scand 1982. 71489–494.494. [PubMed]
4. Overview of allergic diseases: diagnosis, management and barriers to care. The Allergy Report. 2004 American Academy for Allergy, Asthma and Immunology. http://www.theallergyreport.org/ (last accessed 4 November 2005)
5. Report of the IUIS/WHO working group. Use and abuse of 8 widely used diagnostic procedures in clinical immunology: a WHO memorandum. Clin Exp Immunol 1981. 46662–674.674.
6. Good Allergy Practice. Standards of care for providers and purchasers of allergy services within the NHS. 1994. Report by the RCP and RCPath. London: Royal College of Physicians and Royal College of Pathologists, 1994.
7. Allergy. Conventional and alternative concepts. A report of the RCP Committee of Clinical Immunology and Allergy. London: The Royal College of Physicians, 1992.
8. Allergy the unmet need. A blueprint for better patient care. London: Royal College of Physicians, 2003.
9. Guidelines for the study of adverse reactions to food. Position statement approved by the American College of Allergy and Immunology Board of Regents. Ann Allergy 1991. 67299–300.300. [PubMed] 10. Li J T. Allergy testing. Am Fam Physician 2002. 66621–625.625. [PubMed]
11. National Asthma Education and Prevention Program. Guidelines for the diagnosis and management of asthma: expert panel report 2. NIH publication no. 98–4051. Bethesda: NIH, 1997. 43–45.45.
12. Volcheck G W. Which diagnostic tests for common allergies? Postgrad Med 2001. 10971–79.79. [PubMed] 13. Institute of Clinical Systems improvement health care guideline. Menopause and hormone therapy : collaborative decision‐making and management. October 2003. http://www.icsi.org/knowledge/detail.asp?catID=29&itemID=172 (last accessed 14 February 2005) (HT)
14. The Canadian Consensus Conference on Menopause and Osteoporosis 2002 Update. J Obstet Gynaecol Can 2002. 1084–16.16.
15. The North American Menopause Society Menopause core curriculum study guide. 2nd ed. http://www.menopause.org/edumaterials/studyguide/studyguide.htm (last accessed 1 October 2004)
16. AACE medical guidelines for clinical practice for management of menopause. Endocr Pract 1999. 51353–366.366.
17. Groeneveld F P M J, Bijl D, Smulders M. et al The Dutch College of General Practitioners (NHG) practice guideline “The menopause”. September 2001. http://www.nhg.artsennet.nl/upload/104/guidelined2/E73.htm (date accessed 21 June 2004)
18. Gow S M, Turner E L, Glasier A. The clinical biochemistry of the menopause and hormone replacement therapy. Ann Clin Biochem 1994. 3509–528.528. [PubMed] 19. Bastian L A, Smith C M, Nanda K. Is this woman perimenopausal? JAMA 2003. 289895–902.902. [PubMed]
20. Bijl D, Eijkelenburg‐Waterreus J J H, De Jong H M. et al NHG‐standard amenorroea (NHG practice guideline “Amenorrhoea”). In: Thomas S, Geijer RMM, Van der Laan JR, et al, eds. NHG‐Standaarden voor de huisarts deel II [NHG Practice Guidelines for the general practitioner part II]. Utrecht: Bunge, 1996. 54–64.64.
21. Lapworth R, Anslow T, Clawson T. Audit of FSH requesting can alter long term practice. Journal of Clinical Excellence 2002. 417–21.21.
22. Haines C J, Fan S, Tang G W K. et al Guidelines for the administration of hormone replacement therapy. The Hong Kong College of Obstetricians and Gynaecologists. Hong Kong Med J 1999. 5195–199.199. [PubMed] 23. L'Hermite M. Risks of estrogens and progestagens. Maturitas 1990. 12215–246.246. [PubMed] 24. Gangar K, Cust M, Whitehead M I. Symptoms of oestrogen deficiency associated with supraphysiological plasma estradiol concentrations in women with estrodiol implants. BMJ 1989. 299601–602.602. [PMC free article] [PubMed]
25. Alberta Medical Association Laboratory endocrine testing guidelines: amenorrhea (without hirsuitism) and menopause. http://www.topalbertadoctors.org/guidelines/fulltext/amenorrhea.pdf (last accessed 10 October 2004)
26. Green C J, Wai S M, Anderson G M. et alThe erythrocyte sedimentation rate: an examination of the evidence . Vancouver (BC): BC Office of Health Technology Assessment; 1993, Report 924D.
27. Brigden M. The erythrocyte sedimentation rate. Still a helpful test when used judiciously. Postgrad Med 1998. 103257–274.274. [PubMed] 28. Sox H C, Jr, Liang M H. The erythrocyte sedimentation rate. Guidelines for rational use. Ann Intern Med 1986. 104515–523.523. [PubMed] 29. Bedell S E, Bush B T. Erythrocyte sedimentation rate. From folklore to facts. Am J Med 1985. 781001–1009.1009. [PubMed]
30. Miller A, Green M, Robinson D. Simple rule for calculating normal erythrocyte sedimentation rate. BMJ 1983. 286266.
31. Kyle V, Cawston T E, Hazleman B L. Erythrocyte sedimentation rate and C‐reactive protein in the assessment of polymyalgia rheumatica/giant cell arteritis on presentation and during follow up. Ann Rheum Dis 1989. 48667–671.671. [PMC free article] [PubMed] 32. Cantini F, Salvarani C, Olivieri I. et al Erythrocyte sedimentation rate and C‐reactive protein in the evaluation of disease activity and severity in polymyalgia rheumatica: a prospective follow up study. Semin Arthritis Rheum 2000. 3017–24.24. [PubMed] 33. Kyle V, Hazleman B L. The clinical and laboratory course of polymyalgia rheumatica/giant cell arteritis after the first two months of treatment. Ann Rheum Dis 1993. 52847–850.850. [PMC free article] [PubMed]
34. Wolfe F. Comparative usefulness of C‐reactive protein and erythrocyte sedimentation rate in patients with rheumatoid arthritis. J Rheumatol 1997. 241477–85.
35. Li C, Dasgupta B. Corticosteroids in polymyalgia rheumatica—a review of different treatment schedules. Clin Exp Rheumatol 2000. 18(suppl 20)S56–S57.S57. [PubMed]
36. Ward M M. Relative sensitivity to change of the erythrocyte sedimentation rate and serum C‐reactive protein concentration in rheumatoid arthritis. J Rheumatol 2004. 31884–95.
37. Spangehl M J, Masri B A, O'Connell J X. et al Prospective analysis of preoperative and intraoperative investigations for the diagnosis of infection at the sites of two hundred and two revision total hip arthroplasties. J Bone Joint Surg Am 1999. 81672–683.683. [PubMed] 38. Miettinen A K, Heinonen P K, Laippala P. et al Test performance of erythrocyte sedimentation rate and C‐reactive protein in assessing the severity of acute pelvic inflammatory disease. Am J Obstet Gynecol 1993. 51143–1149.1149. [PubMed] 39. Reljic M, Gorisek B. C‐reactive protein and the treatment of pelvic inflammatory disease. Int J Gynaecol Obstet 1998. 60143–150.150. [PubMed] 40. Unkila‐Kallio L, Kallio M J, Eskola J. et al Serum C‐reactive protein, erythrocyte sedimentation rate, and white blood cell count in acute hematogenous osteomyelitis of children. Pediatrics 1994. 9359–62.62. [PubMed] 41. Friedman S, Henry‐Amar M, Cosset J M. et al Therapeutic implications and sites of relapse predicted by elevated post‐therapy erythrocyte sedimentation rate in early stage Hodgkin disease. Am J Hematol 1991. 37253–257.257. [PubMed] 42. Henry‐Amar M, Friedman S, Hayat M. et al Erythrocyte sedimentation rate predicts early relapse and survival in early‐stage Hodgkin disease. The EORTC lymphoma cooperative group. Ann Intern Med 1991. 114361–365.365. [PubMed] 43. Smith E M, Samadian S. Use of the erythrocyte sedimentation rate in the elderly. Br J Hosp Med 1994. 51394–397.397. [PubMed] 44. Tinetti M E, Schmidt A, Baum J. Use of the erythrocyte sedimentation rate in chronically ill, elderly patients with a decline in health status. Am J Med 1986. 80844–848.848. [PubMed]
45. Dacie J V. Practical haematology. 6th ed. Edinburgh: Churchill Livingstone, 1984.
46. Yun E J, Meng M V, Carroll P R. Evaluation of patients with haematuria. Med Clin North Am 2004. 88329–343.343. [PubMed] 47. Malmström P U. Time to abandon testing for microscopic haematuria in adults? BMJ 2003. 326813–815.815. [PMC free article] [PubMed]
48. Shah J. The investigation and management of haematuria—a continuing dilemma. Urooncology 2003. 373–80.80.
49. Chahal R, Gogoi N K, Sundaram S K. Is it necessary to perform urine cytology in screening patients with haematuria? Eur Urol 2001. 39283–286.286. [PubMed] 50. Bove P, Kaplan D, Dalrymple N. et al Re‐examining the value of haematuria testing in patients with acute flank pain. J Urol 1999. 162685–687.687. [PubMed] 51. Duldulao K E, Diokno A C, Mitchell B. Value of urinary cytology in women presenting with urge incontinence and/or irritative voiding symptoms. J Urol 1997. 157113–116.116. [PubMed]
52. Grossfeld G D, Litwin M S, Wolf J S. et al Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association best practice policy—part I: definition, detection, prevalence and etiology. Urology 2001. 57559–603.603.
53. Ezz el Din K, Koch W F, de Wildt M J. et al The predictive value of microscopic haematuria in patients with lower urinary tract symptoms and benign prostatic hyperplasia. Eur Urol 1996. 30409–413.413. [PubMed] 54. Lammers R L, Gibson S, Kovacs D. et al Comparison of test characteristics of urine dipstick analysis and urinalysis at various test cutoff points. Ann Emerg Med 2001. 38505–512.512. [PubMed] 55. Sultana R V, Zalstein S, Cameron P. et al Dipstick urinalysis and the accuracy of clinical diagnosis of urinary tract infection. J Emerg Med 2001. 2013–19.19. [PubMed] 56. Moore K N, Murray S, Malone‐Lee L. et al Rapid urinalysis assays for the diagnosis of urinary tract infection. Br J Nurs 2001. 10995–1001.1001. [PubMed] 57. D'Souza Z, D'Souza D. Urinary tract infection during pregnancy—dipstick urinalysis vs culture and sensitivity. J Obstet Gynaecol 2004. 2422–24.24. [PubMed] 58. Kryszczuk K, Kelsberg G. Should we screen adults for asymptomatic microhaematuria? J Fam Pract 2004. 53150–155.155. [PubMed] 59. Froom P, Froom J, Ribak J. Asymptomatic microscopic haematuria—is investigation necessary? J Clin Epidemiol 1997. 501197–1200.1200. [PubMed] 60. Mansson A, Anderson H, Colleen S. Time lag to diagnosis of bladder cancer—influence of psychosocial parameters and level of health‐care provision. Scand J Urol Nephrol 1993. 27363–369.369. [PubMed] 61. Fracchia J A, Motta J, Miller L S. et al Evaluation of asymptomatic microhematuria. Urology 1995. 46484–489.489. [PubMed] 62. Hiatt R A, Ordenez J D. Dipstick urinalysis screening, asymptomatic microhematuria, and subsequent urological cancers in a population based sample. Cancer Epidemiol Biomarkers Prev 1994. 3439–443.443. [PubMed] 63. Messing E M, Young T B, Hunt V B. et al Comparison of bladder cancer outcome in men undergoing haematuria home screening versus those with standard clinical presentations. Urology 1995. 45387–396.396. [PubMed] 64. Nabi G, Greene D R, O'Donnell M. How important is urinary cytology in the diagnosis of urological malignancies? Eur Urol 2003. 43632–636.636. [PubMed] 65. Sultana S R, Goodman C M, Byrne D J. et al Microscopic haematuria: urological investigation using a standard protocol. Br J Urol 1996. 78691–696.696. [PubMed] 66. Topham P S, Jethwa A, Watkins M. et al The value of urine screening in a young adult population. Fam Pract 2004. 2118–21.21. [PubMed] 67. Hofland C A, Mariani A J. Is cytology required for a haematuria evaluation? J Urol 2004. 171324–326.326. [PubMed] 68. Ramakumar S, Bhuiyan J, Bess J A. et al Comparison of screening methods in the detection of bladder cancer. J Urol 1999. 161388–394.394. [PubMed]
69. World Health Organisation Cancer prevention. http, // www.who.int/cancer/prevention/en (last accessed 19 May 2005)
70. Burton J L, Goepel J R, Lee J A. Demand management in urine cytology: a single cytospin slide is sufficient. J Clin Pathol 2000. 53718–719.719. [PMC free article] [PubMed]
71. Stamm W E. Urinary tract infections and pyelonephritis. In: Harrison's principles of internal medicine. 14th ed. New York: McGraw‐Hill, 2000.
72. Steinke D T, Seaton R A, Phillips G. et al Factors associated with trimethoprim‐resistant bacteria isolated from urine samples. J Antimicrob Chemother 1999. 43841–843.843. [PubMed] 73. Stamm W E, Hooton T M. Managing urinary tract infections in adults. N Engl J Med 1993. 3281328–1334.1334. [PubMed] 74. Warren J W. Catheter‐associated urinary tract infections. Int J Antimicrob Agents 2001. 17229–303.303. [PubMed] 75. Cunningham F G, Lucas M J. Urinary tract infections complicating pregnancy. Baillieres Clin Obstet Gynaecol 1994. 8353–373.373. [PubMed]
76. Urinary tract infection. MeReC Bulletin 1995. 629–32.32.
77. Fenwick E, Briggs A, Hawke C. Management of urinary tract infection in general practice: a cost‐effectiveness analysis. Br J Gen Pract 2000. 50612–613.613. [PMC free article] [PubMed] 78. Graham J C, Galloway A. The laboratory diagnosis of urinary tract infection. J Clin Pathol 2001. 54911–919.919. [PMC free article] [PubMed] 79. Royal College of Physicians Report of a Working Group of the Research Unit. Guidelines for the management of acute urinary tract infection in childhood. J R Coll Physicians Lond 1991. 2536–42.42. [PubMed]
80. McNulty C A M, Bowen J, Clark G. et al How should general practitioners investigate suspected urinary tract infection? Variations in laboratory‐confirmed bacteriuria in South West England. Comm Dis Public Health 2004. 7220–226.226.
81. Turner G M, Coulthard M G. Fever can cause pyuria in children. BMJ 1995. 311924.
82. Abrutyn E, Mossey J, Berlin J A. et al Does asymptomatic bacteriuria predict mortality and does antimicrobial treatment reduce mortality in elderly ambulatory women? Ann Intern Med 1994. 120827–833.833. [PubMed]
83. Rajagopalan S, Rho J P, Yoshikawa T T. An approach to antimicrobial therapy. In: Yoshikawa TT, Ouslander JG, eds. Infection management for geriatrics in long‐term care facilities. New York, USA: Marcel Dekker Inc, 2002. 155–171.171.
84. McMurdo M E, Gillespie N D. Urinary tract infection in old age: over‐diagnosed and over‐treated. Age Ageing 2000. 29297–298.298. [PubMed] 85. Tambyah P A, Maki D G. Catheter‐associated urinary tract infection is rarely symptomatic: a prospective study of 1497 catheterised patients. Arch Intern Med 2000. 160678–682.682. [PubMed] 86. Brumfitt W, Hamilton‐Miller J M, Gillespie W A. The mysterious urethral syndrome [editorial]. BMJ 1991. 3031–2.2. [PMC free article] [PubMed] 87. European Confederation of Laboratory Medicine ( E C L M ) European urinalysis group. European analysis guidelines. Scand J Clin Lab Invest 2000. 601–96.96. [PubMed] 88. Hurlbut TA I I I, Littenberg B., and the Diagnostic Technology Assessment Consortium The diagnostic accuracy of rapid dipstick tests to predict urinary tract infection. Am J Clin Pathol 1991. 96582–588.588. [PubMed] 89. Pezzlo M. Detection of urinary tract infections by rapid methods. Clin Microbiol Rev 1988. 1268–280.280. [PMC free article] [PubMed]
90. Jones C, Bennitt W, Halloran S P. Evaluation of urine reagent strips. Medical Devices Directorate Evaluation Report. London: HMSO, 1998.
91. Health Protection Agency Diagnosis of urinary tract infection—quick reference guide. http://www.hpa.org.uk/infections/topics_az/primary_care_guidance/uti_guide_290404.rtf (last accessed 08 March 2005)
92. Bent S, Nallamouthu B, Simel D. et al Does this woman have an acute uncomplicated urinary tract infection? JAMA 2002. 2872701–2710.2710. [PubMed] 93. Kolmos H, Little P. Should general practitioners perform diagnostic tests on patients before prescribing antibiotics? BMJ 1999. 318799–802.802. [PMC free article] [PubMed] 94. Czerwinski A W, Wilkerson R G, Merrill J A. et al Further evaluation of the Griess test to detect significant bacteriuria. Part II.Am J Obstet Gynecol 1971. 110677–681.681. [PubMed]
95. Scottish Intercollegiate Guidelines Network (SIGN) guidelines on investigation of asymptomatic proteinuria (No. 18) and microscopic haematuria (No. 17) ( http://www.sign.ac.uk )
96. Hooton T M, Stamm W E. Diagnosis and treatment of uncomplicated UTI. Infect Dis Clin North Am 1997. 11551–581.581. [PubMed] 97. Roberts A P, Robinson I E, Beard K W. Some of the factors affecting bacterial colony counts in urinary infection. BMJ 1967. 1400–403.403. [PMC free article] [PubMed] 98. Baerheim A, Digranes A, Hunskaar S. Evaluation of urine sampling technique: bacterial contamination of samples from women students. Br J Gen Pract 1992. 42241–243.243. [PMC free article] [PubMed] 99. Lifshitz W E, Kramer L. Outpatient urine culture. Arch Intern Med 2000. 1502537–2540.2540. [PubMed]
100. Rees J C, Vernon S, Pedler S J. et al Collection of urine from washed‐up potties. Lancet 1996. 348197.
101. Lynster L C T, Nayar D M, Pedler S J. et al Home collection of urine for culture from infants by three methods. Survey of parents' preferences and bacterial contamination rates. BMJ 2000. 3201312–1313.1313. [PMC free article] [PubMed] 102. Gillespie T, Fewster J, Masterton R G. The effect of specimen processing delay on borate urine preservation. J Clin Pathol 1999. 5295–99.99. [PMC free article] [PubMed]
103. Porter I A, Brodie J. Boric acid preservation of urine samples. BMJ 1969. ii353–355.355.